Table 5.
Clinical Parameters | n | Day 0 | Follow-Up | ||
---|---|---|---|---|---|
% | (95% CI) | % | (95% CI) | ||
Lameness day 0 and day 1–2 | 89 | 75.2 | (58.3–95.6) | 44.9 | (32.1–61.2) |
Lameness day 0 and day 3–5 | 83 | 74.7 | (57.3–95.8) | 8.4 | (3.4–17.4) |
Affected general condition, day 0 and day 1–2 | 89 | 39.3 | (27.4–54.7) | 16.9 | (9.4–27.8) |
Affected general condition, day 0 and day 3–5 | 81 | 39.3 | (27.4–54.7) | 10.1 | (4.6–19.2) |
* Non-overlapping confidence intervals was counted as a statistically significant difference.